Cristina Calderón

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

José Falantes, Cristina Calderón, Francisco J. Márquez‐Malaver et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 44 citations

Hematological Malignancy, Antibiotics, Antifungal Agents +10

Overexpression of GYS1, MIF, and MYC Is Associated With Adverse Outcome and Poor Response to Azacitidine in Myelodysplastic Syndromes and Acute Myeloid Leukemia

José Falantes, Pablo Trujillo, José I. Piruat et al. · Clinical Lymphoma Myeloma & Leukemia · 2014 · 37 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +7

To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors

Rocío Parody, Dolores Caballero, Francisco J. Márquez‐Malaver et al. · European Journal Of Haematology · 2013 · 32 citations

The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation

Teresa Caballero‐Velázquez, Luís I. Sánchez-Abarca, Silvia Gutierrez-Cosío et al. · Haematologica · 2012 · 21 citations · Full text

Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories

José Falantes, Cristina Calderón, Francisco J. Márquez‐Malaver et al. · Clinical Lymphoma Myeloma & Leukemia · 2012 · 20 citations

Hematological Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia +10